CVE-2025-9921
code-projects POS Pharmacy System products.php cross site scripting
A weakness has been identified in code-projects POS Pharmacy System 1.0. Affected is an unknown function of the file /main/products.php. This manipulation of the argument product_code/gen_name/product_name/supplier causes cross site scripting. The attack can be initiated remotely. The exploit has been made available to the public and could be exploited.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- High
- User interaction
- Passive
What an attacker can affect
- Confidentiality
- None
- Integrity
- Low
- Availability
- None
Exploit likelihood
What each source reports
CVE List Score used
code-projects POS Pharmacy System products.php cross site scripting
A weakness has been identified in code-projects POS Pharmacy System 1.0. Affected is an unknown function of the file /main/products.php. This manipulation of the argument product_code/gen_name/product_name/supplier causes cross site scripting. The attack can be initiated remotely. The exploit has been made available to the public and could be exploited.
- Record
CVE-2025-9921- CVSS 4.0
- 4.8 Medium
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P - CVSS 3.1
- 2.4 Low
CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:U/C:N/I:L/A:N/E:P/RL:X/RC:R - CVSS 3.0
- 2.4 Low
CVSS:3.0/AV:N/AC:L/PR:H/UI:R/S:U/C:N/I:L/A:N/E:P/RL:X/RC:R - CVSS 2.0
- 3.3
AV:N/AC:L/Au:M/C:N/I:P/A:N/E:POC/RL:ND/RC:UR - Weakness
- CWE-79, CWE-94
- Updated
- 2026-11-02
EUVDEUVD-2025-26606
A weakness has been identified in code-projects POS Pharmacy System 1.0. Affected is an unknown function of the file /main/products.php. This manipulation of the argument product_code/gen_name/product_name/supplier causes cross site scripting. The attack can be initiated remotely. The exploit has been made available to the public and could be exploited.
- Record
EUVD-2025-26606- CVSS 4.0
- 4.8 Medium
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P - Updated
- 2026-11-02
GitHub AdvisoriesGHSA-6g5x-hx8m-w464
A weakness has been identified in code-projects POS Pharmacy System 1.0. Affected is an unknown...
A weakness has been identified in code-projects POS Pharmacy System 1.0. Affected is an unknown function of the file /main/products.php. This manipulation of the argument product_code/gen_name/product_name/supplier causes cross site scripting. The attack can be initiated remotely. The exploit has been made available to the public and could be exploited.
- Record
GHSA-6g5x-hx8m-w464- CVSS 4.0
- 1.9 Low
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X - CVSS 3.1
- 5.4 Medium
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
NVD
A weakness has been identified in code-projects POS Pharmacy System 1.0. Affected is an unknown function of the file /main/products.php. This manipulation of the argument product_code/gen_name/product_name/supplier causes cross site scripting. The attack can be initiated remotely. The exploit has been made available to the public and could be exploited.
- Record
CVE-2025-9921- CVSS 4.0
- 1.9 Low
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X - CVSS 3.1
- 2.4 Low
CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:U/C:N/I:L/A:N - CVSS 3.1
- 5.4 Medium
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N - CVSS 2.0
- 3.3 Low
AV:N/AC:L/Au:M/C:N/I:P/A:N - Weakness
- CWE-79, CWE-94
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| first indexed | CVE List, EUVD, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2025-9921 is a medium vulnerability (CVSS 4.8) in Code-projects Pos Pharmacy System, published September 3, 2025. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.31%, the 23rd percentile. No source names a fixed version.